secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2026-08-03T12:52:10+00:00
Accession:  0001683168-26-005899
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma reduces Series B warrant exercise price to $1.2202 after ATM sales
--------------------------------------------------------------------------------

- Exercise price of Series B warrants reduced to $1.2202 due to recent common stock sales under ATM offering.
- Adjustment triggered by anti-dilution provisions in the warrant terms.
- Further adjustments may occur as set forth in the Series B warrant agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316826005899/0001683168-26-005899-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316826005899/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-005899

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer